Abivax

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Ensho Therapeutics

This biopharmaceutical company develops oral small molecule therapies to treat patients suffering from inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

Altrubio

This clinical-stage biotechnology company develops antibody therapeutics to treat patients suffering from immunological and inflammatory diseases such as ulcerative colitis.

Sorriso

This biopharmaceutical company develops oral antibody therapeutics to treat patients with immune-mediated diseases such as Crohn's disease and ulcerative colitis.

AgomAb Therapeutics

This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.